About UCSF Search UCSF UCSF Medical Center

James G. Kahn, MD, MPH

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
kahn_james

Professor in Residence, Department of Epidemiology and Biostatistics, School of Medicine, UCSF

jgkahn@ucsf.edu

Phone: (415) 476-6642
Box 0936, UCSF
San Francisco, CA 94143-0936

View on UCSF Profiles


Additional Websites


Selected Publications

  1. Kahn JG, Marseille EA. Capsule commentary on Long and Stavert, portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. J Gen Intern Med. 2013 Oct; 28(10):1350.
    View on PubMed
  2. Lai JC, Kahn JG, Tavakol M, Peters MG, Roberts JP. Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant. 2013 Oct; 13(10):2611-8.
    View on PubMed
  3. Kahn JG, Marseille EA. Viral load monitoring for antiretroviral therapy in resource-poor settings: an evolving role. AIDS. 2013 Jun 1; 27(9):1509-11.
    View on PubMed
  4. Yanik EL, Napravnik S, Ryscavage P, Eron JJ, Koletar SL, Moore RD, Zinski A, Cole SR, Hunt P, Crane HM, Kahn J, Mathews WC, Mayer KH, Taiwo BO. Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010. J Acquir Immune Defic Syndr. 2013 Jun 1; 63(2):216-20.
    View on PubMed
  5. Kern E, Verguet S, Yuhas K, Odhiambo FH, Kahn JG, Walson J. Provision of bednets and water filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan multisite study. Trop Med Int Health. 2013 Aug; 18(8):916-24.
    View on PubMed
  6. Sutherland T, Downing J, Miller S, Bishai DM, Butrick E, Fathalla MM, Mourad-Youssif M, Ojengbede O, Nsima D, Kahn JG. Use of the non-pneumatic anti-shock garment (NASG) for life-threatening obstetric hemorrhage: a cost-effectiveness analysis in Egypt and Nigeria. PLoS One. 2013; 8(4):e62282.
    View on PubMed
  7. Audureau E, Kahn JG, Besson MH, Saba J, Ladner J. Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance. BMC Public Health. 2013; 13:286.
    View on PubMed
  8. Marseille E, Lohse N, Jiwani A, Hod M, Seshiah V, Yajnik CS, Arora GP, Balaji V, Henriksen O, Lieberman N, Chen R, Damm P, Metzger BE, Kahn JG. The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med. 2013 May; 26(8):802-10.
    View on PubMed
  9. Velayos FS, Kahn JG, Sandborn WJ, Feagan BG. A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab. Clin Gastroenterol Hepatol. 2013 Jun; 11(6):654-66.
    View on PubMed
  10. Marseille E, Giganti MJ, Mwango A, Chisembele-Taylor A, Mulenga L, Over M, Kahn JG, Stringer JS. Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia. PLoS One. 2012; 7(12):e51993.
    View on PubMed
  11. Abeyasinghe RR, Galappaththy GN, Smith Gueye C, Kahn JG, Feachem RG. Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One. 2012; 7(8):e43162.
    View on PubMed
  12. Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, Sabin ML, Makhlouf-Obermeyer C, De Filippo Mack C, Williams P, Jones L, Smyth C, Kutch KA, Ying-Ru L, Vitoria M, Souteyrand Y, Crowley S, Korenromp EL, Williams BG. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One. 2012; 7(2):e30216.
    View on PubMed
  13. Kahn JG, Muraguri N, Harris B, Lugada E, Clasen T, Grabowsky M, Mermin J, Shariff S. Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness. PLoS One. 2012; 7(2):e31316.
    View on PubMed
  14. Kahn JG, Harris B, Mermin JH, Clasen T, Lugada E, Grabowksy M, Vestergaard Frandsen M, Garg N. Cost of community integrated prevention campaign for malaria, HIV, and diarrhea in rural Kenya. BMC Health Serv Res. 2011; 11:346.
    View on PubMed
  15. Marseille EA, Kevany S, Ahmed I, Feleke G, Graham B, Heller T, Kahn JG, Reyes M. Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study. Cost Eff Resour Alloc. 2011; 9:18.
    View on PubMed
  16. Kahn JG, Marseille E, Moore D, Bunnell R, Were W, Degerman R, Tappero JW, Ekwaru P, Kaharuza F, Mermin J. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011; 343:d6884.
    View on PubMed
  17. Lohse N, Marseille E, Kahn JG. Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus. Int J Gynaecol Obstet. 2011 Nov; 115 Suppl 1:S20-5.
    View on PubMed
  18. Bozic KJ, Chiu V, Slover JD, Immerman I, Kahn JG. Patient preferences and willingness to pay for arthroplasty surgery in patients with osteoarthritis of the hip. J Arthroplasty. 2012 Apr; 27(4):503-506.e2.
    View on PubMed
  19. Tatarsky A, Aboobakar S, Cohen JM, Gopee N, Bheecarry A, Moonasar D, Phillips AA, Kahn JG, Moonen B, Smith DL, Sabot O. Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PLoS One. 2011; 6(9):e23832.
    View on PubMed
  20. Jones L, Akugizibwe P, Clayton M, Amon JJ, Sabin ML, Bennett R, Stegling C, Baggaley R, Kahn JG, Holmes CB, Garg N, Obermeyer CM, Mack CD, Williams P, Smyth C, Vitoria M, Crowley S, Williams B, McClure C, Granich R, Hirnschall G. Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting. Curr HIV Res. 2011 Sep; 9(6):416-28.
    View on PubMed

Go to UCSF Profiles, powered by CTSI